Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PONVORY safely and effectively. See full prescribing information for PONVORY. PONVORY ®(ponesimod) tablets, for oral use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
PONVORY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
- generic_name
- ponesimod
- product_names
- Ponesimod
- ndc
- 50458-720, 50458-707, 50458-720-30, 50458-707-14, 50458-702, 50458-702-00, 50458-703, 50458-703-00, 50458-704, 50458-704-00, 50458-705, 50458-705-00, 50458-706, 50458-706-00, 50458-711, 50458-711-00, 50458-708, 50458-708-00, 50458-709, 50458-709-00, 50458-710, 50458-710-00
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en